# Medella Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medella-health

- Industry: Medical Devices & Equipment
- Headquarters: Hampshire, UK
- Website: www.medella.ca
- Total disclosed funding: $1.4M
- Latest round: Seed (Jun 1, 2016)
- Investors on record: 4

## About

Medella Health Inc. specializes in the development of innovative bio-sensors and electronics for continuous, non-invasive monitoring of critical health indicators, empowering users to proactively manage their health.Medella Health Inc. is focused on creating advanced bio-monitoring technologies. The company was founded by Harry Gandhi and Matthew Tukel. Its headquarters is located in Hampshire, UK. Medella Health raised USD 1.4 mn in Seed funding on June 1, 2016, from investors including 1517 Fund, BDC Capital, Fifty Years, and Garage Technology Ventures. This funding supports the company's strategies in enhancing their product offerings and market reach.Medella Health focuses on the development of next-generation bio-sensors and electronics designed to continuously and non-invasively monitor a variety of bio-markers. Their core product offerings include a range of advanced sensors that aim to empower users to better manage their health through real-time monitoring of critical health indicators. These technologies leverage the company’s expertise in nanotechnology, micro-electronics, and health informatics, targeting end users who seek proactive health management solutions. The products are tailored for markets that prioritize preventative medicine, and they cater to a diverse client base that encompasses healthcare providers, wellness centers, and individual consumers in North America and Europe.Medella Health generates revenue through direct sales to consumers and partnerships with healthcare institutions. The transaction structure involves providing subscription-based access to their bio-monitoring services, allowing clients to benefit from ongoing data analytics and health insights. Clients may also engage in B2B relationships, where healthcare providers offer Medella's technologies to their patients, enhancing their service offerings. While specific pricing plans for individual products or services are not disclosed, the revenue model reflects Medella’s strategy to integrate their bio-sensors into existing healthcare frameworks, ensuring a robust flow of transactions as their technologies gain wider adoption among both healthcare practitioners and consumers.Moving forward, Medella Health plans to expand its product line with new bio-sensing devices aimed at improving user health management. Recent funding will be allocated to developing these products and enhancing their existing technologies. The company also aims to penetrate new markets in Europe and North America, targeting a broader range of healthcare services by 2025, leveraging its latest funding received in June 2016.

## Funding rounds

- Seed, Jun 1, 2016, $1.4M — Garage Technology Ventures, BDC Capital, 1517 Fund, Fifty Years

## Investors

- Garage Technology Ventures (https://capitalatlas.ai/funds/garage-technology-ventures) — Seed
- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Seed
- 1517 Fund (https://capitalatlas.ai/funds/1517-fund) — Seed
- Fifty Years (https://capitalatlas.ai/funds/fifty-years) — Seed